Genomics breakthrough paves way for equitable Cancer Care in Africa
Yemaachi Biotech, a pioneering genomics research firm based in Ghana, in collaboration with Illumina, a global leader in sequencing technology, has announced the arrival of the NovaSeq X Plus in Ghana - a first-of-its-kind high-throughput sequencer.
This is aimed at accelerating cancer research and addressing inequities in cancer care among African populations.
The NovaSeq X Plus, the most powerful sequencer yet developed by Illumina, is expected to significantly enhance research into cancer diagnostics and treatment tailored to African genomes.
This development marks a major milestone in the continent’s efforts to promote equitable access to precision medicine.
In a press release issued to the Ghana News Agency, in Accra, the two institutions explained that globally, can...